Results 111 to 120 of about 203,608 (213)

In Vivo Bioimaging of Mercury Sulfide Nanoparticles Dissolution in the Gut Environment of Zooplankton. [PDF]

ACS Nano
Yan N, Li F, Han D, Yang L, Yin Y, Hu L, Shi J, Jiang G.   +7 more
europepmc   +1 more source

Doktora Tez Tanıtım Yazısı

, 2015
İbrahim Akyol’un hazırlamış olduğu “Fatih Sultan Mehmet Dönemi Kültür ve Edebiyat” başlıklı 496 sayfadan oluşan doktora tezi 2012 yılında Kırıkkale Üniversitesi bünyesinde tamamlanmıştır. Akyol, bu çalışmayı hazırlarken Osmanlı Devleti’nin İstanbul’u fethi ile değişen ilimi, kültürel ve edebi hayatını incelemeye tabi tutmuştur.
openaire   +5 more sources

RFFL-mediated protein quality control limits functional rescue of TRID-CFTR modulator combination therapy for cystic fibrosis nonsense mutations. [PDF]

Cell Mol Life Sci
Tateishi H, Doi Y, Kamada Y, Okiyoneda T.   +3 more
europepmc   +1 more source

PolyA_DB v4: systematic polyA site identification and isoform annotation in human and mouse genomes using 3' end and long-read sequencing data. [PDF]

Nucleic Acids Res
Yu S, Chen WC, Wang L, Jewell S, Mammedova A, Han SW, Wickramasinghe J, Barash Y, Tian B.   +8 more
europepmc   +1 more source

Implications for cystic fibrosis therapy: Potentiator icenticaftor is superior to ivacaftor in improving function and maintaining stability of F508del CFTR. [PDF]

Sci Prog
Cholon DM, Aleksandrov LA, Quinney NL, Boyles SE, Jensen TJ, Aleksandrov AA, Gentzsch M.   +6 more
europepmc   +1 more source

Metatranscriptomic analyses of gut bacterial and viral communities in the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) under distinct environments. [PDF]

Anim Microbiome
Fan S, Liu H, Yan Y, Xu M, Wan X, Hao Y, Gong C, Wang C, Zhang Y, Liu D, Zheng J, Chen J.   +11 more
europepmc   +1 more source

Beyond Trikafta: new models to assess tissue dependent rescue of N1303K-CFTR. [PDF]

Front Pharmacol
Pranke I, Capurro V, Chevalier B, Pesce E, Tomati V, Pastorino C, Kelly-Aubert M, Hatton A, Dreano E, Lena M, Bocciardi R, Zara F, Pantano S, Terlizzi V, Lucanto C, Costa S, Claut L, Daccò V, Poli P, Maschio M, Fabrizzi B, Caporelli N, Cipolli M, Volpi S, Chedevergne F, Cosson L, Macey J, Ramel S, Weiss L, Grenet D, Le Clainche-Viala L, Douvry B, Ravoninjatovo B, Audousset C, Tatopoulos A, Richaud-Thiriez B, Baravalle M, Thouvenin G, Labbé G, Mittaine M, Reix P, Durieu I, Mankikian J, Bui S, Nguyen-Khoa T, Khoukh K, Martin C, Da Silva J, De Carli P, Castellani C, Cresta F, Galietta L, Guillemaut A, Girodon E, Remus N, Bulcaen M, Ensinck M, Zajac M, Carlon M, LeBihan J, Burgel PR, Sermet-Gaudelus I, Hinzpeter A, Pedemonte N.   +63 more
europepmc   +1 more source

Mesenteric Fibromatosis Presenting As Acute Abdominal Pain Mimicking a Perforated Viscus: A Case Report. [PDF]

Cureus
Kostara K, Tez M, Velazquez B, Liguori T, Kostaras V.   +4 more
europepmc   +1 more source

Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study. [PDF]

Eur Respir J
Mall MA, Wainwright CE, Legg J, Chilvers M, Gartner S, Dittrich AM, Stehling F, Conner S, Grant S, Suresh N, Weinstock TG, Davies JC, VX20-445-119 Study Group.   +12 more
europepmc   +1 more source

Aging Gracefully: Does Elexacaftor/Tezacaftor/Ivacaftor Safety and Efficacy Stand the Test of Time? [PDF]

Am J Respir Crit Care Med
Wilson G, Hughes D.
europepmc   +1 more source